Evidence map›Paper›PMID 32654473›Full record

ArticleJournal of clinical research in pediatric endocrinology2020

Association of Exosomal miR-34a with Markers of Dyslipidemia and Endothelial Dysfunction in Children and Adolescents with T1DM

Alshaymaa A. Ibrahim, Aliaa A. Wahby, Ingy Ashmawy, Rehan M. Saleh, Hend Soliman

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical research in pediatric endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Alterations in miRNA Expression and Their Role in the Pathogenesis of Cervical Cancer.Asian Pacific journal of cancer prevention : APJCP · 2024
    Article
  5. Article
  6. Article
  7. Exosomal microRNAs in diabetic heart disease.Cardiovascular diabetology · 2022
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Alshaymaa A. IbrahimNational Research Centre, Department of Clinical and Chemical Pathology, Cairo, EgyptORCID 0000-0002-0673-6532
Aliaa A. WahbyNational Research Centre, Department of Clinical and Chemical Pathology, Cairo, EgyptORCID 0000-0003-1276-2240
Ingy AshmawyNational Research Centre, Department of Clinical and Chemical Pathology, Cairo, EgyptORCID 0000-0002-6598-3568
Rehan M. SalehNational Research Centre, Department of Community, Cairo, EgyptORCID 0000-0003-3693-4211
Hend SolimanCairo University Faculty of Medicine, New Children Hospital, Cairo, EgyptORCID 0000-0003-0225-172X
National Research Centre · EGCairo University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Dyslipidemia and endothelial dysfunction are common disorders and major causative factors for atherosclerosis in patients with type 1 diabetes mellitus (T1DM). However, their pathophysiology in young patients with T1DM is still under evaluated. We aimed, for the first time, to assess the expression of exosomal micro-RNA 34a (miR-34a) in serum of children and adolescents with T1DM and correlate this expression with markers of dyslipidemia and endothelial dysfunction. Methods: The study included 120 T1DM patients and 100 control subjects. Assessment of miR-34a was performed using quantitative real-time polymerase chain reaction. Lipid profile was assessed on an automated analyzer and serum endoglin and intracellular adhesion molecule (ICAM) concentrations were measured using immunometric methods. Results: Relative expression of miR-34a and serum endoglin and ICAM concentrations were higher in patients than controls (p=0.001) and in patients with dyslipidemia (42 patients) compared to patients without dyslipidemia (78 patients) (p=0.01). Linear regression analysis revealed a strong independent association between exosomal miR-34a expression and total cholesterol, low-density lipoprotein, serum endoglin and serum ICAM after adjustment for other cofactors. The utility of miR-34a as an indicator for associated dyslipidemia was tested using receiver operator characteristic curve analysis which revealed area under the curve: 0.73 with confidence interval: 0.63-0.83 and p=0.001. Conclusion: This was the first study to show the altered expression of exosomal miR-34a among children and adolescents with T1DM. Moreover, association of miR-34a with markers of dyslipidemia and endothelial dysfunction was identified, suggesting that it could play a role in regulation of lipid metabolism and endothelial function in T1DM.

Indexed as

AdolescentCase-Control StudiesChildCross-Sectional StudiesDiabetes Mellitus, Type 1DyslipidemiasEgyptEndothelium, VascularExosomesFemaleFollow-Up StudiesHumansMaleMicroRNAsPrognosisSignal TransductionMicroRNAsMIRN34 microRNA, humandyslipidemiaendoglinendothelial dysfunctionintracellular adhesion moleculemiR-34atype 1 diabetes mellitus

Identifiers

PMID32654473
PMCPMC7711647
OpenAlexW3043049272

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.